by | Feb 21, 2024 | Luff, Stephanie, Sturgeon, Christopher
— T-018886 — Scalable Generation of Hematopoietic Progenitors from Human Pluripotent Stem Cells
Technology Description
In vitro generation of CD34+ hematopoietic progenitor cells (HPC) that faithfully recapitulate in vivo behavior is an area of ongoing research. A key characteristic of CD34+ …
by | Feb 13, 2024 | Chheda, Milan, Diamond, Michael, Gorman, Matthew
— T-017429 Engineered Oncolytic Zika Virus Therapy for Glioblastoma
Technology Description
Researchers in the laboratories of Michael Diamond and Milan Chheda at Washington University have developed prospective treatments for glioblastoma (GBM) through the application of an engineered Zika virus (ZI…
by | Feb 6, 2024 | Jha, Abhinav Kumar, Rahman, Md Ashequr, Siegel, Barry, Yu, Zitong
— T-020357, T-020358, T-020744 Myocardial perfusion SPECT optimization
Technology Description
Researchers from the laboratory of Abhinav Jha at Washington University have devised methods to reliably improve and personalize myocardial perfusion SPECT imaging. The inventions include the following capa…
by | Feb 6, 2024 | Jha, Abhinav Kumar, Rahman, Md Ashequr, Siegel, Barry, Yu, Zitong
— T-020357, T-020358, T-020744 Myocardial perfusion SPECT optimization
Technology Description
Researchers from the laboratory of Abhinav Jha at Washington University have devised methods to reliably improve and personalize myocardial perfusion SPECT imaging. The inventions include the following capa…
by | Jan 19, 2024 | Lomonosova, Elena, Mullen, Mary, Verma, Priyanka, Zhao, Peinan
— T-020659 — Functional Biomarkers of Platinum Chemotherapy and PARP Inhibitor Response
Technology Description
Most patients diagnosed with high-grade serous ovarian cancer (HGSOC) undergo first-line platinum therapy and PARP inhibitor maintenance therapy. However, the degree to which HGSOC p…